Tofacitinib as treatment for refractory dermatomyositis: A retrospective study from 2 academic medical centers

Min, M. S., Alsarheed, A., Kassamali, B., Mazori, D. R., Schaefer, M., Merola, J. F., … Vleugels, R. A. (2022). Tofacitinib as treatment for refractory dermatomyositis: A retrospective study from 2 academic medical centers. Journal of the American Academy of Dermatology, 86(2), 423–425. https://doi.org/10.1016/j.jaad.2021.07.003